000 01306 a2200385 4500
005 20250515043345.0
264 0 _c20070315
008 200703s 0 0 eng d
022 _a0007-0963
024 7 _a10.1111/j.1365-2133.2006.07437.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTom, W L
245 0 0 _aEfalizumab-induced autoimmune pancytopenia.
_h[electronic resource]
260 _bThe British journal of dermatology
_cNov 2006
300 _a1045-7 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAutoimmune Diseases
_xchemically induced
650 0 4 _aCD11a Antigen
_ximmunology
650 0 4 _aDermatologic Agents
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aPancytopenia
_xchemically induced
650 0 4 _aPsoriasis
_xdrug therapy
700 1 _aMiller, M D
700 1 _aHurley, M Y
700 1 _aSuneja, T
700 1 _aKudva, G
700 1 _aLeonardi, C L
700 1 _aObadiah, J M
773 0 _tThe British journal of dermatology
_gvol. 155
_gno. 5
_gp. 1045-7
856 4 0 _uhttps://doi.org/10.1111/j.1365-2133.2006.07437.x
_zAvailable from publisher's website
999 _c16610920
_d16610920